-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017203-gurwitz-final-report-2011.pdf
January 01, 2011 - requirement, as it may be too
stringent in a number of instances (e.g., liver function testing relevant to statin
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017163-baker-final-report-2011.pdf
January 01, 2011 - and female, or male
LDL-C < 100 mg/dL Medical reason, patient reason ,
prescribed high potency statin
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
November 01, 2020 - for Impaired
Visual Acuity & Glaucoma
Screening for Type 2
Diabetes in Children &
Adolescents
Statin
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp5.pdf
October 01, 2011 - Nutritional Research Series: Volume 5: Comparison of Translational Patterns in Two Nutrient–Disease Associations
Technical Review 17
Nutritional Research Series
Volume 5: Comparison of Translational Patterns in Two
Nutrient–Disease Associations
Prepared for:
A…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
January 01, 2014 - management and
disease management)
• Drug therapy services for a single drug
(e.g., warfarin clinics, statin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
March 10, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 10, 2010
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of Medications to Reduce Risk of
Primary B…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/36geybKjEXsHDoPkRR5KVZ
June 01, 2008 - Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement
Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive
Services Task Force Recommendation Statement
U.S. Preventive Services Task Force*
Description: Updated U.S. Preventive Services Task Force (…
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs014882-ferranti-final-report-2008.pdf
January 01, 2008 - /Warf Miscellaneous 28.6% N/A 0.0%
173 Amiodarone & Statin Miscellaneous N/A N/A 1.2%
153 Amiodarone
-
effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
December 01, 2009 - A comparison of
propensity score methods: a case-study
estimating the effectiveness of post-AMI
statin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
December 01, 2009 - A comparison of
propensity score methods: a case-study
estimating the effectiveness of post-AMI
statin
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023952-chrischilles-final-report-2018.pdf
January 01, 2018 - antithrombotic or aspirin therapy; (5) history of ischemic stroke or myocardial
infarction (MI) not receiving statin
-
www.ahrq.gov/sites/default/files/2025-04/schiff-mcnutt-report.pdf
January 01, 2025 - systematic error.
13
The team has also piloted multiple other lab-pharmacy linkages, including statin
-
cdsic.ahrq.gov/sites/default/files/2025-03/Copy%20of%20Final_MO_Patient%20Preference%20Inventory_6.7.24_508.xlsx
January 01, 2025 - Comparisons with Personalized Patient Preferences: A Randomized Trial of an Interactive Platform for Statin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Type 2 diabetes is characterized by insulin
resistance accompanied by progressive
deficiency in insulin secretion. Type 2
diabetes is an increasingly common disease
that is closely associated with obesity. In
2005, the prevalence of Americans with
diagnosed type 2 diabetes was 2.4 percent
for ad…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
July 08, 2014 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Carotid Artery Stenosis: Screening
July 08, 2014
Recommendations made by the USPSTF are independent of the U.S. government. They should not be …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MLeu_yFpPwzcZwKG6fw5ZY
April 26, 2022 - Statin use
for the primary prevention of cardiovascular
disease in adults: US Preventive Services Task
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - (eg, not vs. statin)
O • Must mention CVD (or BP or lipids) in abstract
• All-cause mortality
•
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - Layout 1
Background
Nearly 2,400 Americans die of
cardiovascular disease each day, an average
of one death every 36 seconds.
Cardiovascular disease claims more lives
each year than cancer, chronic lower
respiratory diseases, accidents, and
diabetes mellitus combined. An estimated
79,400,000 American adults (one in …
-
www.ahrq.gov/sites/default/files/2024-02/berry-report.pdf
January 01, 2024 - Final Progress Report: HIV/HCV Support Team to Improve Medication Safety and Engagement in Care
Final Progress Report
HIV/HCV Support Team to Improve Medication Safety and Engagement in Care
Principal Investigator: Stephen A. Berry, MD, PhD
Team Members: David Thompson, PhD; Elizabeth Holmes, RN; Janessa M. Smith…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/XAaYbGVD_xRoMfQ-huJkJq
December 10, 2019 - or peripheral artery disease were counseled to initiate preven-
tive interventions, with aspirin and statin … Statin use
for the primary prevention of cardiovascular
disease in adults: US Preventive Services Task